Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Mortality Benefit of Coffee Diminishes With Added Sugar and Saturated Fat

Only black coffee and coffee with low added sugar and saturated fat are associated with lower mortality risk, according to a study published online May 12 in th

Grip Provides Insight Into Psychosis, Study Says

TUESDAY, July 1, 2025 Get a grip might be a truer saying for holding onto sanity than previously thought, a new study says. A loss of grip strength might be an

IBS Rates Nearly Doubled During the Pandemic

MONDAY, July 1, 2025 The COVID-19 pandemic took a toll on Americans guts, researchers report. Gut disorders like irritable bowel syndrome (IBS) increased signif

Medicaid, Medicare Don't Adequately Cover Addiction Treatment, Study Says

TUESDAY, July 1, 2025 Opioid addicts covered by Medicare and Medicaid are less likely to receive the mental health and substance use treatment that they need, a

AI Can Help Determine A Person's Specific Form Of Dementia

TUESDAY, July 1, 2025 A new AI tool can help doctors hone in on a patient s particular type of dementia, including Alzheimer s disease, a new study says.The AI

Moderna’s New Flu Shot Shows Strong Results in Older Adults

TUESDAY, July 1, 2025 Moderna s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the com

Monthly News Roundup - June 2025

Dupixent Approved in the U.S. as the First Targeted Medicine to Treat Patients with Bullous Pemphigoid Dupixent (dupilumab) has been approved for the treatment

UCB Announces Positive Results from GEMZ Phase 3 Study of Fenfluramine in CDKL5 Deficiency Disorder

Brussels, Belgium 27th June 2025 UCB, a global biopharmaceutical company, today announced that the phase 3 study investigating the safety and efficacy of adjunc

Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. R

Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer

Amgen (NASDAQ AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary en

Popular Keywords